Log In
Print
BCIQ
Print
Print this Print this
 

Scenesse, afamelanotide (CUV1647) (formerly Melanotan)

Also known as: formerly EPT1647 implant

  Manage Alerts
Collapse Summary General Information
Company Clinuvel Pharmaceuticals Ltd.
DescriptionSustained-release subcutaneous implant of synthetic alpha melanocyte stimulating hormone (MSH)
Molecular Target Melanocortin 1 receptor (MC1R)
Mechanism of ActionMelanocortin 1 receptor (MC1R) agonist
Therapeutic ModalityMedical Devices: Drug/device combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$82.2M

$82.2M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today